Welcome - Welkom

Annual General Meeting of Shareholders

Algemene Vergadering van

Aandeelhouders

The Hague, May 15, 2020

Helping people achieve a lifetime of financial security

William L. Connelly

Chairman of the Supervisory Board

Voorzitter van de Raad van Commissarissen

2

Welcome to the Annual

Welkom bij de jaarlijkse

General Meeting of

Algemene Vergadering van

Shareholders

Aandeelhouders

3

Agenda item 1 │ Agendapunt 1

OpeningOpening

This item will not be voted upon / Over dit agendapunt wordt niet gestemd

4

Agenda item 2 │ Agendapunt 2

2019

Presentatie over de gang

Business overview

van zaken in 2019

This item will not be voted upon / Over dit agendapunt wordt niet gestemd

5

Living up to our purpose in testing times

Alex Wynaendts

CEO & Chairman of the Executive Board

The Hague, May 15, 2020

Helping people achieve a lifetime of financial security

Today's storyline

  • Impact ofCOVID-19
    • People
    • Customers
    • Operations
    • Financials
  • Briefly looking back on 2019
    • Focus on growth and capital
    • Active portfolio management
    • Financial highlights
  • Living up to our purpose

7

We are living in testing times

With huge impact on customers and employees

  • COVID-19impacts:
    • People
    • Operations
    • Customers
    • Financials
  • Main responsibilities:
    • Ensuring safety of our employees
    • Fulfilling promises to our customers by maintaining strong capital position
    • Supporting our communities

8

Our response to COVID-19 crisis

Health and safety of employees primary responsibility; continued operations

  • Crisis management
    • Effective crisis management governance in place; global guidance - local implementation
  • Working from home
    • Stable working from home environment was enabled for all our employees across the world
  • Engagement
    • Global framework introduced to sustainwell-being, engagement and productivity of employees
  • Continuity of critical services ensured
    • While working from home
  • Business continuity of critical outsourcing partners
    • Shown to be robust
  • Enhancing use of digital solutions
    • For answering customer questions

9

Our response to COVID-19 crisis

Providing guidance and financial relief to our customers

Ensuring uninterrupted customer service

Increased customer appraisal

  • No material pandemic exclusions
    • After outbreak,COVID-19 coverage included in critical illness product China
  • Providing premium payment and fee

flexibility

    • Case-by-caseapproach for insurance, pensions and mortgages
  • Offering relevant solutions and advice
    • Launch oftele-health in Spain and Portugal providing 24 hrs. medical advice for free

10

Our response to COVID-19 crisis

Supporting our communities

  • Our businesses responded with local initiatives for immediate support
  • For a total of over EUR 1 million to date
  • Initiatives include:

US:providing protective gear to frontline healthcare workers

Across Europe:donating medical supplies and food to the elderly and helping supply protective gear to healthcare workers

UK:dedicated corporate donation for local charity to be decided by employees

NL:support healthcare workers

Asia:supporting

insurance; laptops for children

hospitals and relief

for home schooling

and developments

organizations,

supplying personal

protective equipment

and promoting health

education

11

Execution of strategy in 2019

  • Environment remained challenging
    • Persistent low interest rates in our key markets
    • Customers impacted by economic uncertainty
    • Growing need for solidarity and financial security
  • Further simplified our organization
    • Reorganization of US businesses
    • Aegon International launched
  • Investing in the future
    • Responsible business
    • Leveraging technology
    • Build-upanalytics capabilities

12

Continued focus on growth and capital in 2019

Improved commercial momentum while we continued to invest in customer services

  • Increase in Life, Accident & Health sales and gross deposits during the year

Capturing opportunities in fast-growing markets

Financial protection and investment management in India and China

Strong normalized capital generation of EUR 1.6 billion over 2019

Up 12% compared with 2018

Solid Group Solvency II ratio of 201% per year-end 2019

All business units also strongly capitalized

13

Successfully optimizing our portfolio

Underlying earnings before tax(in EUR million, FY2019)

Manage for Value

Drive for Growth

Reinsured a quarter of longevity risk in

Positive momentum in Life and Accident

the Netherlands

& Health sales, as well as gross deposits

New own employee pension plan protects

35%

€ 1,973

Eighth consecutive full year of positive

capital position and reduces volatility

55%

external third-party net inflows for Aegon

million

Successful transfer of policy

Asset Management

administration to Atos in the UK

Realized targeted expense savings from

10%

Cofunds integration

Scale-up for Future

  • Continue expanding our digital platforms
    • New partnership with a largee-commerce player in China, driving sales growth
  • Agreed partnership with leading mobile wallet MobiKwik in India to launch smart digital insurance product

Completed divestment of variable annuity joint ventures in Japan

14

Purpose more relevant than ever before

As already recognized 175 years ago

Purpose

Helping people achieve a lifetime of

financial security

  • Strategic transformation

TransformationFinancial transformation

  • Organizational & cultural transformation

Financial

Solid balance sheet

strength

Strong liquidity position

To continue to live up to our purpose - also in

these testing times

15

Agenda item 3 │ Agendapunt 3

Annual Report and

Jaarverslag en

Annual Accounts 2019

jaarrekening 2019

16

Agenda item 3.1 │ Agendapunt 3.1

Reports of the Boards

Verslagen van de

for 2019

Raad van Bestuur en de

Raad van Commissarissen

over 2019

This item will not be voted upon / Over dit agendapunt wordt niet gestemd

17

Our financial performance in 2019

Matt Rider

CFO & Member of the Executive Board

The Hague, May 15, 2020

Helping people achieve a lifetime of financial security

Today's storyline

  • Financial highlights 2019
  • Key performance indicators 1Q 2020
  • Balance sheet preservation
  • Target outlook

19

Financial highlights 2019

IFRS

Capital position

per year-end

Underlying earnings

Group solvency ratio

EUR 1,973 million

201%

-5% compared with 2018

-10pp compared with 2018

Net income

Holding excess cash

EUR 1,528 million

EUR 1,192 million

Up EUR 784 million from 2018

Within target range

Return on equity

Gross financial leverage

9.5%

28.5%

-70bp compared with 2018

-70bp compared with 2018

Capital generation and

dividend

Capital generation1

EUR 1,569 million

+12% compared with 2018

Gross remittances

to holding

EUR 1,365 million2

Dividend per share3

EUR 0.15

1. Capital generation excluding market impact and one-time items after holding funding & operation expenses

20

  1. Excludes EUR 100 million remittances by Aegon the Netherlands to the Group in February 2020; EUR 1,518 million including sale of stake in Japan JVs
  2. On April 2, 2020, EIOPA and DNB published statements urging insurers to temporarily postpone all dividend distributions. Proposed final 2019 dividend of EUR 0.16 per share was subsequently cancelled on April 3, 2020

Our key performance indicators in 1Q 2020

Underlying earnings

Net income

Normalized capital

Group Solvency II

Holding excess

before tax

generation

ratio

cash

€ 366 million

€ 1,270 million

€ 311 million

208%

€ 1,379 million

21

Solid capital position in units and at Group level

Group Solvency II ratio

201%

208%

200%

Target range

150%

Year-end

March

2019

31, 2020

Group Solvency II ratio at March 31, 2020

  • Group Solvency II ratio slightly above the target range supported by normalized capital generation
  • Benefit from rising credit spreads, in particular in the Netherlands, were partly offset by adverse market movements in the US

Group Solvency II ratio at the end of April

  • Estimated at 190% to 200%
  • Mainly driven by narrowing of credit spreads

Solvency II ratio main units at March 31, 2020

  • All main units above thebottom-end of their respective target ranges
  • Decline in US RBC ratio is mainly due to lower interest rates and equity markets
  • Increase in NL Solvency II ratio mainly due to widening of credit spreads
  • Stable UK Solvency II ratio reflecting balance sheet light business model

Local solvency ratio by unit

Year-end 2019 and 1Q 2020

US - RBC

470%376%

NL - SII

171% 249%

UK - SII 157% 160%

Notes: 1. Numbers are based on management's best estimates, 2. Bottom-end of the target range US = 350% RBC; bottom-end of the target range NL = 155% Solvency II; bottom-end of

22

the target range UK = 145% Solvency II

Protecting the economic value of the balance sheet

Management actions

Hedging and

Underwriting

Capital

asset allocation

and pricing

preservation

  • Rebalanced macro equity hedge to increase downside protection and control hedging costs towards a more linear protection
  • Increasing focus of reinvestments on higher rated credit (>55% A rated or higher) in areas less affected by theCOVID-19 crisis
  • Focusing on new issuances in corporate bonds to benefit from higher spreads
  • Increasing scrutiny and monitoring in potentiallycrisis-affected asset classes
  • Variable annuity repricing in 2Q20 to lead to lower withdrawal rates and lower guarantees
  • Launched a new variable annuity product on BaNCS platform with principal protection and upside potential suited for these markets
  • Specific new business underwriting requirements introduced, e.g.
    • Restricting coverage for new policies for certain age groups in the US
    • Postponements of certain coverages with confirmedCOVID-19 exposure in US
    • Adjusted underwriting criteria in travel and income protection in Netherlands
  • Legal merger of core US Life entities improving asset adequacy testing sufficiency
  • Continuing to pursue options for accelerating capital generation in Manage for Value businesses
  • Increasing focus on operational excellence to preserve earnings and therewith capital generation, including limiting project and discretionary spend as far as possible

23

Focus on maintaining solid financial position despite challenging conditions

Financial position and outlook

(March 31, 2020)

Group Solvency II ratio

208%

Holding excess cash

EUR 1.4 billion

Return on Equity target

Very unlikely to reach 10%

return on equity target in 2020 given

the extraordinary circumstances

Other medium-term targets

Difficult to provide a full assessment

of COVID-19 related impacts on

medium-term targets

24

Agenda item 3.1 │ Agendapunt 3.1

Reports of the Boards

Verslagen van de

for 2019

Raad van Bestuur en de

Raad van Commissarissen

over 2019

This item will not be voted upon / Over dit agendapunt wordt niet gestemd

25

Agenda item 3.2 │ Agendapunt 3.2

Annual Accounts 2019 and

Jaarrekening 2019 en rapport

report independent auditor

van de onafhankelijke

accountant

This item will not be voted upon / Over dit agendapunt wordt niet gestemd

26

Gert-Jan Heuvelink

15 May 2020

Presentation by PwC

15 May 2020

Audit of Aegon's 2019 Financial Statements

  • Audit opinion(refer to pages 328 to 336 of the Annual Report)
  • Materiality
  • Scope of our group audit
  • Risk of fraud andnon-compliance with laws and regulations
  • Key audit matters:
    • Valuation of certain assets and liabilities arising from insurance contracts
    • Valuation of certain level 3 investments
    • Uncertainties in policyholder claims and litigation
  • Subsequent event procedures /Covid-19 outbreak
  • Other information included in the Annual Report

15 May 2020

PwC

29

Agenda item 3.2 │ Agendapunt 3.2

Annual Accounts 2019 and

Jaarrekening 2019 en rapport

report independent auditor

van de onafhankelijke

accountant

This item will not be voted upon / Over dit agendapunt wordt niet gestemd

30

Agenda item 3.3 │ Agendapunt 3.3

Remuneration Report 2019

Remuneratierapport 2019

This item will be subject to an advisory vote / Over dit agendapunt wordt een adviserende stem uitgebracht

31

Ben Noteboom

Chairman of the Remuneration Committee

Voorzitter van de Remuneratie Committee

32

Supervisory Board Remuneration Policy 2019

2019 Supervisory Board fees

Fees

Scope

Base Fee

Supervisory Board membership

Risk or Audit Committee membership

Membership of other Committees

Attendance Fee

Committee meetings

For extra Supervisory Board meetings (>6)

Travel Fee

To attend Supervisory Board (Committee)

meeting

Amount(in EUR)

80,000 per year - Chairman

50,000 per year - Vice-Chairman

40,000 per year - Members

13,000 per year - Chairman

8,000 per year - Members

10,000 per year - Chairman

5,000 per year - Members

3,000 per meeting

3,000 per meeting

2,000 for continental or US-interstate travel

4,000 for intercontinental travel

33

Supervisory Board remuneration in 2019

Remuneration received in 2019

In EUR thousands

Base Fee

Attendance Fee

Travel Fee

Total

Connelly

95

54

20

169

Ellman

56

39

20

115

Noteboom

58

39

6

103

Van der Veer

58

54

6

118

Wortmann - Kool

63

54

6

123

Young

66

66

26

158

Dineen*

40

27

12

79

Total

436

333

96

865

* Up to October 11, 2019

34

Executive Board Remuneration Policy 2019

Compensation and benefit overview

Component

Details

Fixed compensation

Paid in monthly installments

Variable compensation

Target/maximum: 80%/100% of fixed compensation

Pay-out:

40% upfront

60% deferred, tranche vesting over 3-yr period (3x 20%)

Each portion paid 50:50 in cash/shares

All shares subject to additional 3-year holding period

Pension

40% of fixed compensation*

28% of fixed compensation - grandfathered arrangement Mr. Wynaendts

Other benefits

E.g. company car, social security and tax paid by employer

* Up to May 2019, an end of term arrangement applied to Mr. Wynaendts.

35

Executive Board remuneration in 2019

Remuneration received in relation to 2019

In EUR thousands

Fixed

Variable**

Pension

Benefits

Total

Wynaendts*

1,314

1,048

1,302

252

3,916

Rider

931

743

373

77

2,124

Total

2,245

1,791

1,675

329

6,040

* Pension Mr. Wynaendts: includes Jan-May end of term arrangement, June-Dec 40% of fixed compensation.

36

** Awarded in relation to 2019 performance year (to be paid in 2020-2023).

Executive Board variable compensation in 2019

2019 Aegon results for calculation Executive Board variable compensation

37

Executive Board variable compensation in 2019 (cont'd)

2019 results Mr. Wynaendts for variable compensation calculation

38

Executive Board variable compensation in 2019 (cont'd)

2019 results Mr. Rider for variable compensation calculation

39

Executive Board remuneration in 2020

Annualized remuneration levels per January 2020

In EUR thousands

Fixed

Variable

Pension

Total

Wynaendts

1,327

Target:

80%

40%

Target: 3,318

+ 2% allowance*

Max: 100%

+ 28%*

Max: 3,584

Friese **

1,485

Target:

80%

40%

Target: 3,267

Max: 100%

Max: 3,564

Rider

941

Target:

80%

40%

Target: 2,070

Max: 100%

Max: 2,258

* Grandfathered arrangements (2% allowance and 28% pension).

** When appointed. Received a separate sign-on arrangement of EUR 1.25 mln in March 2020 when hired, which is split in (almost) half cash and the other half in Aegon shares. Half of the sign-on payment has been paid upfront and the other half is deferred to vesting dates in future years.

40

Agenda item 3.3 │ Agendapunt 3.3

Remuneration Report 2019

Remuneratierapport 2019

This item will be subject to an advisory vote / Over dit agendapunt wordt een adviserende stem uitgebracht

41

Agenda item 3.4 │ Agendapunt 3.4

Adoption of the

Vaststelling van de

Annual Accounts 2019

jaarrekening 2019

42

Agenda item 3.5 │ Agendapunt 3.5

DividendDividend

This item will not be voted upon / Over dit agendapunt wordt niet gestemd

43

Dividend

  • In its Annual Report 20191), Aegon proposed a final 2019 dividend of EUR 0.16 per common share and EUR 0.004 per common share B, absent further deterioration of the market circumstances, and based on the assessments made at that time
  • Subsequently, Aegon decided to forego the 2019 final dividend to comply with the call2)made by EIOPA and DNB
  • Therefore, the total dividend for financial year 2019 is the interim dividend of EUR 0.15 per common share and EUR 0.00375 per common share B, paid in September 2019
  • Aegon will review opportunities for returning capital to its shareholders as soon as appropriate
  • Aegon will take a decision on the 2020 interim dividend in August 2020 in line with our dividend policy, taking circumstances and outlook at that time into consideration

1)The Annual Report 2019 was published on March 18, 2020.

44

  1. On April 2, 2020, EIOPA and DNB published statements urging insurers to temporarily postpone all dividend distributions.

Agenda item 3.5 │ Agendapunt 3.5

DividendDividend

This item will not be voted upon / Over dit agendapunt wordt niet gestemd

45

Agenda item 4 │ Agendapunt 4

Release from liability

Kwijting

46

Agenda item 4.1 │ Agendapunt 4.1

Release from liability for the

Verlenen van kwijting aan de

members of the

leden van de Raad van Bestuur

Executive Board for their duties

voor de uitoefening van hun

performed during 2019

taak in 2019

47

Agenda item 4.2 │ Agendapunt 4.2

Release from liability for the

Verlenen van kwijting aan de

members of the

leden van de Raad van

Supervisory Board for their

Commissarissen voor de

duties performed during 2019

uitoefening van hun taak in

2019

48

Agenda item 5 │ Agendapunt 5

RemunerationRemuneratie

49

Ben Noteboom

Chairman of the Remuneration Committee

Voorzitter van de Remuneratie Committee

50

Agenda item 5.1 │ Agendapunt 5.1

Adoption of the Remuneration

Vaststelling van het

Policy for members of the

remuneratiebeleid voor de

Executive Board

leden van de Raad van Bestuur

51

Proposed Executive Board Remuneration Policy

Main change 1: Increase alignment with shareholders by increasing shares in pay-mix

Component

Current

Proposed

Pay-mix of

variable compensation

50%

33.33%

in cash

in cash

50%

66.67%

in Aegon

in Aegon

shares

shares

52

Proposed Executive Board Remuneration Policy (cont'd)

Main change 2: Simplification by moving from tranche-vesting to cliff-vesting

Component

Current

Proposed

Vesting schedule of

Yr 0

+1

+2

+3

+4

+5

+6

Yr 0

+1

+2

+3

+4

+5

variable compensation

20%

33.3%

20%

3 years

10%

10%

3 years

10%

66.7%

2 years

10%

3 years

10%

10%

3 years

Cash

Cash

Shares

Holding period

Shares

Holding period

53

Proposed Executive Board Remuneration Policy (cont'd)

Main change 3: Increase long-term focus with introduction 3-year performance period

Component

Current

Proposed

Performance period

1 year for all indicators

3 years for at least 20% of indicators

1 year for all other indicators

Illustration of proposal

(t-2)

(t-1)

Plan

(t+1)

(t+4)

(t+6)

year (t)

3-year performance

One variable

33.33% upfront

in cash

compensation

1-yearAllocation

award

Pay-out

66.67%

2-year

perfor

-

deferred

mance

in Aegon

holding period

for plan year (t)

shares

54

Proposed Executive Board Remuneration Policy (cont'd)

Main change 4: Increase transparency and stakeholder alignment with mandatory categories

Component

Current

Proposed

Performance indicator

≥ 50% non-financial (by law)

≥ 50% non-financial (by law)

mix

Mandatory performance indicator

categories

Proposed categories

Category

Examples of performance indicators

Shareholders

Relative Total Shareholder Return

Capital

Normalized Capital Generation, Solvency II ratio

Earnings

Return on Equity, Underlying Earnings, Earnings per Share

Sales

Market Consistent Value of New Business, Fees and Premium based Revenues, Annualized Revenue on Deposits

Stakeholders

Net Promotor Score, Products per Customer, Employee Training, Employee Turnover

ESG

Employee Engagement, Employee Diversity, Risk Management, Governance

Strategy

Strategy Execution

55

2020 Executive Board performance indicators

Based on proposed policy changes

2019 performance indicators

2020 performance indicators

Category

Aegon financial

Aegon non- financial

Personal

Performance indicators

Net Deposits

Normalized Capital Generation

Return on Equity

Market Consistent Value of New Business Solvency II ratio

Underlying Earnings Before Tax

New Life Sales

Relational Net Promotor Score

Digitally connected customers

Strategy execution

Control environment

Succession planning

Cultural transformation

Mandatory category

Performance indicators

Shareholders

Relative TSR

Capital

Normalized Capital Generation

Earnings

Return on Equity

Sales

Market Consistent Value of New Business

Fees and Premium based Revenues

Stakeholders

Relational Net Promotor Score

Strategy

Execution of key strategic projects

Personal indicators: CEO handover, strategy

execution and transformation projects

ESG

Personal indicators: employee engagement,

diversity & inclusion and control environment

56

Proposed Executive Board Remuneration Policy (cont'd)

Summary of main remuneration elements

Component

Details

Total remuneration

Internal references: Management Board and general employee

level

population

External references: market trends, inflation, European insurance

peer group, Dutch AEX peer group

Fixed compensation

Base Fee: In cash, optionally in shares

Variable compensation

Target: 80% of fixed compensation

Maximum: 100% of fixed compensation

Subject to collective plan rules, incl. malus and claw back clauses

Pension

40% of fixed compensation

Other benefits

E.g. company car, social security and tax paid by employer.

57

Agenda item 5.2 │ Agendapunt 5.2

Adoption of the Remuneration

Vaststelling van het

Policy for members of the

remuneratiebeleid voor de

Supervisory Board

leden van de

Raad van Commissarissen

58

Proposed Supervisory Board Remuneration Policy

Main policy changes

Component

Current

Fees

2019 fee

levels

Policy-considerations

Not included

Proposed

  • No change to 2019 Fee levels
  • Option to index the Fees each year for economic developments (e.g. inflation)
  • Any Fee change exceeding this level or change in the scope of a Fee, still requires Shareholder approval
  • Explanation how the Policy contributes to Aegon's strategy,long-term interests and sustainability
  • Explanation how the Supervisory Board took Aegon's identity, purpose, values and stakeholder environment into account when drafting the Policy

59

Agenda item 5 │ Agendapunt 5

RemunerationRemuneratie

60

Agenda item 6 │ Agendapunt 6

Composition of the

Samenstelling van de

Supervisory Board

Raad van Commissarissen

61

Agenda item 6.1 │ Agendapunt 6.1

Appointment of Mr. Thomas

Benoeming van de heer

Wellauer as member of the

Thomas Wellauer als lid van de

Supervisory Board

Raad van Commissarissen

62

Thomas Wellauer

  • Age: 64
  • Nationality: Swiss
  • Main occupation
    • Non-executivedirector
  • Main former occupation
    • COO of Swiss Re
  • Membership of other Boards
    • Chairman of the Board of Directors of SIX(non-listed)
    • Chairman of the Board of Trustees of the University Hospital Zurich Foundation(non-listed)
    • Member of the Global Executive Board of the International Chamber of Commerce(non-listed)*

* The board membership at International Chamber of Commerce will end on June 30, 2020

63

Agenda item 6.1 │ Agendapunt 6.1

Appointment of Mr. Thomas

Benoeming van de heer

Wellauer as member of the

Thomas Wellauer als lid van de

Supervisory Board

Raad van Commissarissen

64

Agenda item 6.2 │ Agendapunt 6.2

Appointment of Mrs. Caroline

Benoeming van mevrouw

Ramsay as member of the

Caroline Ramsay als lid van de

Supervisory Board

Raad van Commissarissen

65

Caroline Ramsay

  • Age: 57
  • Nationality: British
  • Main occupation
    • Senior finance and audit roles in Financial Services
  • Main former occupation
    • Group Chief Auditor of RSA plc.
  • Membership of other Boards
    • Non-ExecutiveAudit Committee Chair of Brit Syndicates Ltd. (non-listed)
    • Non-ExecutiveAudit Committee Chair of Standard Life UK Smaller Companies Trust plc.
    • Non-ExecutiveAudit Committee Chair of Tesco Underwriting Ltd. (non-listed)
    • Member of FCA Regulatory Decisions Committee and Member of the Payment Systems Regulator Enforcement Decisions Committee(non-listed)
    • Non-ExecutiveAudit Committee Chair of Scottish Equitable plc., Aegon UK, and Cofunds Ltd. (non-listed)*

* The board memberships at Scottish Equitable plc., Aegon UK, and Cofunds Ltd. will end should Mrs. Ramsay be

66

appointed to the Supervisory Board of Aegon N.V.

Agenda item 6.2 │ Agendapunt 6.2

Appointment of Mrs. Caroline

Benoeming van mevrouw

Ramsay as member of the

Caroline Ramsay als lid van de

Supervisory Board

Raad van Commissarissen

67

Agenda item 7 │ Agendapunt 7

Composition of the

Samenstelling van de

Executive Board

Raad van Bestuur

68

Agenda item 7.1 │ Agendapunt 7.1

Appointment of Mr. Lard Friese

Benoeming van de heer

as member of the

Lard Friese als lid van de

Executive Board

Raad van Bestuur

69

Lard Friese

  • Age: 57
  • Nationality: Dutch
  • Shares in the company:
    • None
  • Main former occupation:
    • Chair of the Executive Board and CEO of NN Group
  • External Board membership that qualify under Act Management and Supervision:
    • None

70

Agenda item 7.1 │ Agendapunt 7.1

Appointment of Mr. Lard Friese

Benoeming van de heer

as member of the

Lard Friese als lid van de

Executive Board

Raad van Bestuur

71

Agenda item 8 │ Agendapunt 8

Cancellation, issuance, and

Intrekking, uitgifte en verkrijging

acquisition of shares

van aandelen

72

Agenda item 8 │ Agendapunt 8

  1. Proposal to cancel common shares and common shares B
  2. Authorization of the Executive Board to issue common shares with or withoutpre-emptive rights
  3. Authorization of the Executive Board to issue shares in connection with a rights issue
  4. Authorization of the Executive Board to acquire shares in the Company
  1. Voorstel tot intrekking van gewone aandelen en gewone aandelen B
    Machtiging van de Raad van Bestuur tot uitgifte
  2. van gewone aandelen met of zonder voorkeursrechten
    Machtiging van de Raad van Bestuur tot uitgifte
  3. van gewone aandelen in verband met een claimemissie
  4. Machtiging van de Raad van Bestuur tot verkrijging van eigen aandelen door de Vennootschap

73

Agenda item 9 │ Agendapunt 9

Any other business

Wat verder ter tafel komt

This item will not be voted upon / Over dit agendapunt wordt niet gestemd

74

Agenda item 10 │ Agendapunt 10

ClosingSluiting

This item will not be voted upon / Over dit agendapunt wordt niet gestemd

75

Attachments

  • Original document
  • Permalink

Disclaimer

AEGON NV published this content on 14 May 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 15 May 2020 08:09:03 UTC